乐普医疗涨2.01%，成交额2.73亿元，主力资金净流入236.08万元

Core Viewpoint - Lepu Medical has shown significant stock performance with a year-to-date increase of 63.10%, despite a recent decline of 3.84% over the last five trading days [1] Financial Performance - For the first half of 2025, Lepu Medical reported revenue of 3.369 billion yuan, a year-on-year decrease of 0.43%, and a net profit attributable to shareholders of 691 million yuan, down 0.91% year-on-year [2] - The company has distributed a total of 4.657 billion yuan in dividends since its A-share listing, with 1.758 billion yuan distributed over the past three years [3] Shareholder Information - As of June 30, 2025, Lepu Medical had 100,100 shareholders, an increase of 6.18% from the previous period, with an average of 16,152 circulating shares per shareholder, a decrease of 5.82% [2] - The top ten circulating shareholders include notable ETFs, with Hua Bao Zhong Zheng Medical ETF holding 43.7211 million shares, an increase of 701,700 shares from the previous period [3]